Kusnandi Rusmil, Chief, Covid-19 Vaccine Research & Clinical Trial Team: We Got a Head Start to Develop the Vaccine Faster

Monday, August 3, 2020

The phase III clinical trial of Sinovac Biotech Ltd’s Covid-19 vaccine has generated a lot of interest from prospective volunteers. Four days after the open registration began, over 1,000 volunteers have signed up for the trial conducted by the research team from the faculty of medicine of the Padjadjaran University in Bandung, West Java.

. tempo : 176914577246.

THE research team needed 1,620 volunteers from among Bandung residents for the trial. Besides being required to be healthy and free of Covid-19, potential candidates must be 18 to 59 years old. “I’m looking for the age group with a relatively strong immune system,” Kusnandi Rusmil, 70, the team leader, said during a special interview with Tempo via video conference on Tuesday, July 28.

The trial offers new hope as the case

...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 750.000/12 months

*Flexible payment methods
*Unlimited access to Tempo Plus & Tempo Magz

Rp 386.280/6 months

*Auto-renews every 6 months
*Cancel at anytime
*Unlimited access to Tempo Plus & Tempo Magz

See Other Packages

Already a Subscribed?
To receive daily news by Email,